ClinicalTrials.gov
ClinicalTrials.gov Menu

Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00670605
Recruitment Status : Terminated
First Posted : May 2, 2008
Last Update Posted : March 24, 2011
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Vanderbilt University

Brief Summary:

RATIONALE: Gathering information about the number of young patients with cancer and the outcome of these patients may help doctors learn more about cancer.

PURPOSE: This research study is looking at the medical records of young patients undergoing cancer treatment at the Vanderbilt-Ingram Cancer Center to determine how often cancer occurs and the outcome of these patients.


Condition or disease Intervention/treatment
Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Other: medical chart review Other: study of socioeconomic and demographic variables

Detailed Description:

OBJECTIVES:

  • To determine the number of patients between 15 and 30 years old who are treated for newly diagnosed cancer at the Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and in the state of Tennessee between 1990 and 2005.
  • To determine the outcomes of these patients.
  • To determine the number of these patients enrolled on clinical trials at VICC.
  • To compare the outcomes of these patients when treated on a trial versus not treated on a trial provided they have the same disease.
  • To compare the number of these patients who are treated on a clinical trial when they are first seen at Vanderbilt Children's Hospital vs Vanderbilt University Hospital.
  • To determine referral patterns of these patients to VICC.
  • To compare the outcomes of these patients who are treated at VICC vs middle Tennessee vs the state of Tennessee vs the entire nation.
  • To determine the reason for not enrolling on a clinical trial.

OUTLINE: Cancer cases taken from the Vanderbilt-Ingram Cancer Center (VICC) Registry and the Tennessee Cancer Registry are examined for number and types of cancer, mortality rates broken down by county and health department region, electronic medical records, and treatment outcomes. Data is analyzed for comparison of number of new cancer patients, mortality rates, and referral patterns at VICC versus number of new cancer patients in the region, state, and country.


Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Official Title: VICC Adolescent and Young Adult Oncology Review
Study Start Date : June 2007
Actual Primary Completion Date : December 2009



Primary Outcome Measures :
  1. Number of patients with newly diagnosed cancer from 1990 to 2005 and treated at Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and the state of Tennessee
  2. Comparison of outcomes
  3. Number of patients enrolled in clinical trials at VICC
  4. Outcomes of patients treated on a trial vs those not treated with the same disease
  5. Comparison of number of patients treated at Vanderbilt Children's Hospital vs Vanderbilt University Hospital
  6. Referral patterns
  7. Reason for not enrolling on a clinical trial


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Newly diagnosed
Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of cancer

    • Newly diagnosed disease from 1990 to 2005
    • 15 to 30 years old at the time of cancer diagnosis
  • Must live in the state of Tennessee

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00670605


Locations
United States, Tennessee
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States, 37064
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States, 37064
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838
Sponsors and Collaborators
Vanderbilt University
National Cancer Institute (NCI)
Investigators
Study Chair: Anderson B. Collier, MD Vanderbilt Children's Hospital

ClinicalTrials.gov Identifier: NCT00670605     History of Changes
Other Study ID Numbers: CDR0000584244
P30CA068485 ( U.S. NIH Grant/Contract )
VU-VICC-PED-0732
VU-VICC-070568
First Posted: May 2, 2008    Key Record Dates
Last Update Posted: March 24, 2011
Last Verified: March 2011

Keywords provided by Vanderbilt University:
unspecified adult solid tumor, protocol specific
unspecified childhood solid tumor, protocol specific

Additional relevant MeSH terms:
Neoplasms